According to Chemical Business NewsBase Wednesday, December 31, 2008 the
Australian biotech market has had recent difficulties securing capital due to the global recession. Many desalination and other green projects have been put at risk. There are about 130 listed life science companies in Australia and an estimated 420 private companies. In 2008, two companies, Apollo Life Sciences and Portland Orthopaedics entered administration.
Thus, although green strategies can help to overcome the effects of climate change the effect of the global downturn has an even more marked effect.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment